Αποτελέσματα Αναζήτησης
30 Σεπ 2024 · SPDR ® S&P Biotech ETF earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.
30 Σεπ 2024 · XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar.
28 Ιουν 2024 · Here are seven of the best biotech ETFs to buy today: "There is a high risk of failure for biotech companies, as innovations must undergo years of clinical trials and a failure can destroy the...
31 Οκτ 2024 · The Medalist Ratings indicate which investments Morningstar believes are likely to outperform a relevant index or peer group average on a risk-adjusted basis over time.
30 Σεπ 2024 · Review the latest XBI Morningstar rating and analysis on the ETF to determine if it is the right investment decision for your goals.
Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
24 Ιουν 2024 · Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the...